StockNews.com assumed coverage on shares of Lipocine (NASDAQ:LPCN – Get Rating) in a research note published on Monday morning. The brokerage issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Trading Down 5.4 % Lipocine stock opened at $0.31 on Monday. The firm has a 50-day moving average of $0.47 and a 200-day […]